IAIM
ONCY
International Assets Investment Management’s Oncolytics Biotech ONCY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Hold |
206,900
| – | – | 0.01% | 782 |
|
|
2025
Q1 | $114K | Buy |
206,900
+6,500
| +3% | +$3.58K | 0.01% | 745 |
|
|
2024
Q4 | $186K | Buy |
200,400
+26,069
| +15% | +$24.2K | 0.02% | 755 |
|
|
2024
Q3 | $200K | Sell |
174,331
-24,069
| -12% | -$27.6K | 0.55% | 40 |
|
|
2024
Q2 | $196K | Sell |
198,400
-3,052
| -2% | -$3.02K | 0.02% | 719 |
|
|
2024
Q1 | $214K | Buy |
201,452
+1,675
| +0.8% | +$1.78K | 0.02% | 654 |
|
|
2023
Q4 | $270K | Sell |
199,777
-1,676
| -0.8% | -$2.26K | 0.03% | 530 |
|
|
2023
Q3 | $449K | Buy |
201,453
+6,490
| +3% | +$14.5K | 0.06% | 295 |
|
|
2023
Q2 | $507K | Buy |
194,963
+6,340
| +3% | +$16.5K | 0.07% | 270 |
|
|
2023
Q1 | $226K | Buy |
188,623
+4,840
| +3% | +$5.81K | 0.03% | 442 |
|
|
2022
Q4 | $300K | Buy |
183,783
+2,207
| +1% | +$3.6K | 0.03% | 470 |
|
|
2022
Q3 | $223K | Buy |
181,576
+1,250
| +0.7% | +$1.54K | 0.05% | 345 |
|
|
2022
Q2 | $182 | Hold |
180,326
| – | – | 0.02% | 402 |
|
|
2022
Q1 | $285K | Buy |
180,326
+6,815
| +4% | +$10.8K | 0.05% | 330 |
|
|
2021
Q4 | $241K | Buy |
173,511
+2,935
| +2% | +$4.08K | 0.04% | 405 |
|
|
2021
Q3 | $357K | Buy |
170,576
+8,750
| +5% | +$18.3K | 0.06% | 300 |
|
|
2021
Q2 | $448K | Sell |
161,826
-116,026
| -42% | -$321K | 0.08% | 252 |
|
|
2021
Q1 | $885K | Buy |
277,852
+157,076
| +130% | +$500K | 0.08% | 233 |
|
|
2020
Q4 | $287K | Buy |
120,776
+27,365
| +29% | +$65K | 0.05% | 297 |
|
|
2020
Q3 | $158K | Buy |
93,411
+60,724
| +186% | +$103K | 0.04% | 331 |
|
|
2020
Q2 | $61K | Buy |
32,687
+18,548
| +131% | +$34.6K | 0.01% | 372 |
|
|
2020
Q1 | $20K | Buy |
+14,139
| New | +$20K | 0.01% | 362 |
|